Beta Bionics, Inc. Common Stock BBNX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$21.9M+23.6% | -$13.47M+25.6% | -$14.21M-45.9% | -$16.87M-16.6% | -$28.66M-130% | ||
| $585K+93.1% | $538K+132% | $385K+15.6% | $347K+16.1% | $303K+5.6% | ||
| $5.41M+92.8% | $4.3M+177% | $4.48M+127% | $4.8M+220% | $2.8M+107% | ||
| -$23.83M-19.3% | -$8.63M+39.6% | -$8.73M+9.2% | -$13.59M-11.1% | -$19.98M-64.5% | ||
| $1.38M+314% | $1.9M+239% | $1.28M-33.3% | $1.78M+251% | $333K-18.0% | ||
| $21.84M+112% | —— | —— | —— | -$179.12M-2,443% | ||
| $623K-99.7% | $1.06M-98.1% | $2.65M+326% | $42K+139% | $211.12M+3,518,550% | ||
| -$1.37M-111% | —— | $3.41M-23.4% | —— | $12.02M+368% | ||
| -$25.21M-24.1% | -$10.53M+29.0% | -$10.01M+13.2% | -$15.37M-20.6% | -$20.31M-61.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beta Bionics, Inc. Common Stock generate?
- Beta Bionics, Inc. Common Stock (BBNX) generated -$54.8M in operating cash flow over the trailing twelve months.
- What is Beta Bionics, Inc. Common Stock's free cash flow?
- After $6.3M of capital expenditures, Beta Bionics, Inc. Common Stock's free cash flow was -$61.1M over the trailing twelve months, down 2.9% year over year.
- Where does Beta Bionics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
